Chlamydia trachomatis - the agent

被引:6
|
作者
Cevenini, R [1 ]
Donati, M [1 ]
Sambri, V [1 ]
机构
[1] Univ Bologna, Policlin S Orsola, Sez Microbiol, DMCSS, I-40138 Bologna, Italy
关键词
chlamydia trachomatis; elementary body; reticulate body; developmental cycle; major outer membrane protein; lipopolysaccharicle; heat shock protein; glucosaminoglycan-binding chlamydial proteins; inclusion; inclusion membrane proteins; type III protein secretion; polymorphic membrane proteins; pgp3; protein; plasmid;
D O I
10.1053/beog.2002.0323
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Chlamydiae are obligate intracellular bacteria, parasitizing eukaryotic cells. Chlamydia trachomatis, C. psittaci and C. pneumoniae are the three species of chlamydiae pathogenic to humans. C. trachomatis shows a tropism for the genital and conjunctival epithelia and consists of 19 different serovars which are pathogenic predominantly for the urogenital tract. A distinguishing feature of chlamydiae is their transition between the infectious elementary body that enters the host cell and the non-infectious reticulate body that replicates intracellularly within an inclusion that does not fuse with lysosomes. Chlamydiae depend for some functions upon the host cell; in particular, chlamydiae have little capacity for generating energy. The complete sequence of the 1000-kb chromosome of C. trachomatis is known, as are most of the genes located on the 7.5-kb cryptic plasmid. Recently, several concepts about the biology and the metabolic pathways of C. trachomatis have been revised in relation to the genome sequence, and different novel proteins have been described.
引用
收藏
页码:761 / 773
页数:13
相关论文
共 50 条
  • [1] Molecular pathogenesis of Chlamydia trachomatis
    Jury, Brittany
    Fleming, Charlotte
    Huston, Wilhelmina M.
    Luu, Laurence Don Wai
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [2] May Chlamydia trachomatis be an aetiological agent of chronic prostatic infection?
    Ouzounova-Raykova, V.
    Ouzounova, I.
    Mitov, I. G.
    ANDROLOGIA, 2010, 42 (03) : 176 - 181
  • [3] Chlamydia trachomatis: the Persistent Pathogen
    Witkin, Steven S.
    Minis, Evelyn
    Athanasiou, Aikaterini
    Leizer, Julie
    Linhares, Iara M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2017, 24 (10)
  • [5] Problems With Understanding Chlamydia trachomatis Immunology
    Brunham, Robert C.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (11) : 2043 - 2049
  • [6] Evolution of Chlamydia trachomatis
    Clarke, Ian N.
    EVOLUTION OF INFECTIOUS AGENTS IN RELATION TO SEX, 2011, 1230 : E11 - E18
  • [7] The immunology of Chlamydia trachomatis
    Zdrodowska-Stefanow, B
    Ostaszewska-Puchalska, I
    Pucilo, K
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2003, 51 (05) : 289 - 294
  • [8] Chlamydia trachomatis infections in teenagers [Chlamydia-trachomatis-infektionen bei teenagern]
    Gille G.
    Klapp C.
    Der Hautarzt, 2007, 58 (1): : 31 - 37
  • [9] Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection
    K. Hokynar
    S. Korhonen
    P. Norja
    J. Paavonen
    M. Puolakkainen
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 49 - 56
  • [10] Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis
    Parker, Samantha E.
    Werler, Martha M.
    Gissler, Mika
    Surcel, Helja-Marja
    BIRTH DEFECTS RESEARCH, 2017, 109 (08): : 543 - 549